4E10, a molecule described in detail by Researchers Dennis Burton and Ian Wilson of Scripps Research Institute in their publication entitled "Broadly Neutralizing Anti- HIV antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion - Associated Motif in gp41" with co- authors RM Cardoso , MB Zwick, RL Stanfield, R Kunert, JM Binley and H. Katinger, published in Immunity, Volume 22(2), pages 163-73 on February 2005 was voted as the Molecule of the Year 2005 by the Members of the International Society for Molecular and Cell Biology Protocols and Researches, Inc.(ISMCBPR). 4E10 was chosen among the six prestigious nominated molecules and these include the Lysophosphatidic acid (LPA); Baf60c, Herstatin, Angiotensin Converting Enzyme 2 (ACE-2) and the Fruitless Gene. This took place during the International Scientific Programme 2005 at the AVR, Graduate and Continuing Education Building of the University of the Philippines in the Visayas, Iloilo City, Philippines on December 14, 2005.
Visit the Molecule of the Year 2005 Web Page:
Visit the Scripps Research Institute Home Page for the Press Release of 4E10 as the Molecule of the Year 2005
Submitted by "Prof. Isidro Savillo" - E-mail: email@example.com
Message posted by: Frank S. Zollmann
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...